Statement Of Income

Nxera Pharma Co., Ltd. - Filing #7272710

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of income
Statement of income
Net sales
Net sales
6,581,000,000 JPY
5,015,000,000 JPY
Operating revenue
Cost of sales
Cost of sales
2,284,000,000 JPY
646,000,000 JPY
Operating expenses
Personnel expenses
2,617,000,000 JPY
1,633,000,000 JPY
Depreciation
1,403,000,000 JPY
622,000,000 JPY
Operating expenses
Selling, general and administrative expenses
Operating expenses
Operating expenses - general
Operating profit (loss)
-4,624,000,000 JPY
-335,000,000 JPY
Gross profit
Gross profit (loss)
4,297,000,000 JPY
4,369,000,000 JPY
General and administrative expenses
Non-operating income
Interest income
361,000,000 JPY
132,000,000 JPY
Ordinary profit (loss)
-1,545,000,000 JPY
-3,301,000,000 JPY
Extraordinary income
3,696,000,000 JPY
7,000,000 JPY
Selling, general and administrative expenses
Non-operating income
3,335,000,000 JPY
132,000,000 JPY
Financial revenue
Non-operating income
Miscellaneous income
5,000,000 JPY
0 JPY
Non-operating expenses
Interest expenses
215,000,000 JPY
74,000,000 JPY
Non-operating expenses
Non-operating expenses
Non-operating expenses
256,000,000 JPY
3,098,000,000 JPY
Financial expenses
Share issuance costs
JPY
71,000,000 JPY
Bond issuance costs
JPY
1,092,000,000 JPY
Miscellaneous losses
26,000,000 JPY
26,000,000 JPY
Profit (loss) before income taxes
2,151,000,000 JPY
-3,294,000,000 JPY
Extraordinary income
Income taxes - current
7,000,000 JPY
-9,000,000 JPY
General and administrative expenses
Income taxes
7,000,000 JPY
-9,000,000 JPY
Profit (loss)
2,144,000,000 JPY
2,144,000,000 JPY
2,144,000,000 JPY
-3,285,000,000 JPY
-3,285,000,000 JPY
-3,285,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.